GlassScriptPrepare for your visit
Mikaela D Rush
Obstetrics & Gynecology · Cedar Park, TX · NPI 1093924268
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$5,342.44
in general payments reported to CMS, 2019-2025 · $575 in 2025
The $575 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Who reported paying
General payments only, top 6 by amount.
- Lumenis Be INC $2,266.36
- Abbvie INC. $493.49
- Minerva Surgical, INC $470.85
- Hologic Sales and Service, LLC $367.57
- Medtronic, INC. $139.86
- Evofem Biosciences, INC. $131.04
Drugs and devices associated with these payments
M22 Aptima Zurzuvae Veozah Slynd Ligasure Accrufer Acessa Provu System Truclear Novasure Intrarosa Paragard T 380a
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Mikaela Rush listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/50054/mikaela-d-rush